-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Upgrades Quince Therapeutics to Market Outperform, Announces $77 Price Target

Benzinga·09/22/2026 12:52:04
Diffusion vocale
Citizens analyst Jonathan Wolleben upgrades Quince Therapeutics (NASDAQ:QNCX) from Market Perform to Market Outperform and announces $77 price target.